Cetera Investment Advisers
VKTX icon

Cetera Investment Advisers’s Viking Therapeutics VKTX Stock Holding History

Cetera Investment Advisers’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.2M Sell
184,543
-4,485
-2% -$145K 0.01% 1355
2026
Q1 		$6.15M Sell
189,028
-608
-0.3% -$19.5K 0.01% 1359
2025
Q4 		$6.67M Buy
189,636
+1,165
+0.6% +$41.3K 0.01% 1277
2025
Q3 		$4.95M Buy
188,471
+30,833
+20% +$920K 0.01% 1411
2025
Q2 		$4.18M Buy
157,638
+13,289
+9% +$350K 0.01% 1312
2025
Q1 		$3.49M Buy
144,349
+58,168
+67% +$1.84M 0.01% 1347
2024
Q4 		$3.47M Buy
86,181
+5,634
+7% +$321K 0.01% 1265
2024
Q3 		$5.1M Buy
80,547
+31,236
+63% +$1.83M 0.01% 990
2024
Q2 		$2.61M Buy
49,311
+26,270
+114% +$1.72M 0.01% 1376
2024
Q1 		$1.89M Buy
+23,041
New +$1.03M ﹤0.01% 1598

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Cetera Investment Advisers's VKTX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Viking Therapeutics (VKTX) stake by 2.4% in Q2 2026, selling an estimated $145K and leaving 184,543 shares worth $7.2M. The position accounts for 0.01% of the portfolio, ranked #1355.

Cetera Investment Advisers first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Cetera Investment Advisers held 184,543 shares of Viking Therapeutics worth $7.2M as of Q2 2026.
  • Cetera Investment Advisers sold 4,485 Viking Therapeutics shares in Q2 2026, an estimated $145K.
  • Viking Therapeutics made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1355 holding.
  • Cetera Investment Advisers first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.